Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
-0.26 (-0.52%)
Jul 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 49.39 - 50.24
52 week 37.71 - 58.15
Open 49.75
Vol / Avg. 192,642.00/194,846.00
Mkt cap 1.13B
P/E 36.47
Div/yield 0.12/0.97
EPS 1.36
Shares 22.41M
Beta 0.97
Inst. own 104%
Oct 27, 2016
Abaxis Inc Annual Shareholders Meeting (Estimated) - 1:00PM EDT - Add to calendar
Oct 25, 2016
Q2 2017 Abaxis Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 21, 2016
Q1 2017 Abaxis Inc Earnings Call
Jul 21, 2016
Q1 2017 Abaxis Inc Earnings Release
Jun 7, 2016
Abaxis Inc at Jefferies Healthcare Conference
Jun 1, 2016
Abaxis Inc at Stifel Dental & Veterinary Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin 11.94% 14.20%
Operating margin 18.62% 21.18%
EBITD margin - 24.24%
Return on average assets 10.05% 11.50%
Return on average equity 11.55% 13.61%
Employees 549 -
CDP Score - -


3240 Whipple Rd
UNION CITY, CA 94587-1217
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Officers and directors

Clinton H. Severson Chairman of the Board, Chief Executive Officer
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald Peter Wood President, Chief Operating Officer
Age: 63
Bio & Compensation  - Reuters
Ross Taylor Chief Financial Officer, Vice President - Finance, Secretary
Age: 52
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 62
Bio & Compensation  - Reuters
Craig M. Tockman Vice President - Animal Health Sales and Marketing for North America
Age: 55
Bio & Compensation  - Reuters
Achim Henkel Managing Director of Abaxis Europe GmbH
Age: 57
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 69
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 72
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 70
Bio & Compensation  - Reuters
Henk J. Evenhuis Independent Director
Age: 72
Bio & Compensation  - Reuters